MedPath
HSA Approval

DORAMA-NEO EYE DROPS

SIN04624P

DORAMA-NEO EYE DROPS

DORAMA-NEO EYE DROPS

June 12, 1990

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSATO PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderSATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SOLUTION

OPHTHALMIC

Medical Information

S01XA20

artificial tears and other indifferent preparations

Manufacturer Information

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL CO LTD

Active Ingredients

SODIUM CHLORIDE

0.64%

Sodium chloride

POTASSIUM CHLORIDE

0.13%

Potassium chloride

CALCIUM CHLORIDE

0.02%

Calcium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DORAMA-NEO EYE DROPS - HSA Approval | MedPath